İlgili bildiri özeti aşağıda dikkatinize sunulmuştur. Bildiri özetini ilgili linkler aracılığı ile yazdırabilir, pdf doküman olarak kaydedebilir yada kabul yazısı alabilirsiniz.

PDF Kaydet Yazdır
Kongre Program

Tark 2016

S-47

AuraGainTM and I-Gel® Laryngeal Masks in General Anesthesia for Laparoscopic Cholecystectomy – Performance Characteristics and Effects on Hemodynamics

Ülkü Sabuncu1, Hatice Selcuk Kusderci3, Mesut Oterkus4, Ruslan Abdullayev2, Aslı Demir1, Oznur Uludag2, Sabri Ozdas5, Mustafa Goksu5

1Department of Anesthesiology and Reanimation, Yuksek Ihtisas Research and Educational Hospital,Turkey
2Department of Anesthesiology and Reanimation, Adiyaman University Research and Educational Hospital, Turkey
3Department of Anesthesiology and Reanimation, Bandırma State Hospital,Turkey
4Department of Anesthesiology and Reanimation, Kafkas University Research and Educational Hospital, Turkey
5Department of General Surgery, Adiyaman University Research and Educational Hospital, Turkey


Background and aim of the study: The standard procedure used for airway control in general anesthesia for LC (laparoscopic cholecystectomy) is endotracheal intubation (EI). AuraGain and I-Gel are supraglottic airway devices (SADs) used for airway control for certain types of surgeries. The aim of this study was to evaluate and compare the performances of new types of SADs with EI regarding their insertion times, durations, perioperative complications and effects on hemodynamic parameters and peak airway pressures (Paw) in LC as well. MATERIALS-METHODS: One hundred and fourteen patients with ASA 1-2 physical status scheduled for elective LC were recruited for the study. The patients were divided into AuraGainTM (Ambu, Ballerup, Denmark), I-Gel® (Intersurgical Ltd, UK), and endotracheal tube (ETT) groups, each with 38 patients. Insertion times, duration of insertion, complications, and hemodynamic variables were compared. RESULTS: The study was completed with 105 patients. The groups AuraGain, I-Gel and ETT contained 38, 35 and 32 patients, respectively. Insertion times for SADs, attempts to insertion and complications related to the airway devices were similar between the groups. Heart rate (HR), systolic and diastolic arterial pressures (SAP/DAP), and Paws were significantly lower in the AuraGain and I-Gel groups, compared with the ETT, P < 0.001. CONCLUSION: Both AuraGain and I-Gel laryngeal mask airways (LMAs) are comparable with ETT used for airway control in general anesthesia for LC, regarding application ease, insertion duration and perioperative complications. Favorable hemodynamic responses to AuraGain and I-Gel LMAs may put them in a better place than ETT.